BioWorld Today interview – Ariana’s algorithms to separate signal from noise

You are here: Home » BioWorld Today interview – Ariana’s algorithms to separate signal from noise

Jul 17, 2013 dm (0)

Ariana Pharma SA is developing software to guide the selection of personalized cancer care as part of a clinical trial in patients which, the study investigators claim, will be the first to offer all participants a treatment regimen based on their individual DNA, RNA and microRNA profiles.

Read the full BioWorld Today interview with Mohammad Afshar online (subscription required).

Links: Read online